Misstatements in Artemisinin-Based Combination Therapies in Malaria Treatment

J Clin Pharmacol. 2022 Oct;62(10):1321-1322. doi: 10.1002/jcph.2113. Epub 2022 Jul 5.

Authors

Lawrence Fleckenstein¹, Robert M Miller²

Affiliations

¹ Department of Pharmaceutical Sciences and Experimental Therapeutics, College of Pharmacy, University of Iowa, Iowa City, Iowa, USA.
² Artemida Pharma Limited, Stevenage Bioscience Catalyst, Stevenage, UK.

PMID: 35726879
DOI: 10.1002/jcph.2113

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Antimalarials* / therapeutic use
Artemisinins* / therapeutic use
Drug Resistance
Drug Therapy, Combination
Humans
Malaria* / drug therapy

Substances

Antimalarials
Artemisinins
artemisinin